0001412408-17-000002.txt : 20171211 0001412408-17-000002.hdr.sgml : 20171211 20171211121025 ACCESSION NUMBER: 0001412408-17-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171211 DATE AS OF CHANGE: 20171211 EFFECTIVENESS DATE: 20171211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Phreesia, Inc. CENTRAL INDEX KEY: 0001412408 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-298315 FILM NUMBER: 171248894 BUSINESS ADDRESS: STREET 1: 432 PARK AVENUE S. STREET 2: 12TH FLOOR CITY: New York STATE: ny ZIP: 10016 BUSINESS PHONE: 646-747-9959 MAIL ADDRESS: STREET 1: 432 PARK AVENUE S. STREET 2: 12TH FLOOR CITY: New York STATE: ny ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Phreesia Inc DATE OF NAME CHANGE: 20070914 D/A 1 primary_doc.xml X0708 D/A LIVE 0001412408 Phreesia, Inc. 432 PARK AVENUE S. 12TH FLOOR New York NY NEW YORK 10016 646-747-9959 DELAWARE Phreesia Inc Corporation true Chaim Indig 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Executive Officer Director Charles Kallenbach 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Executive Officer Thomas Altier 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Executive Officer Edward Cahill 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Director Michael Weintraub 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Director Victor Kats 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Director Alan Spoon 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Director Dusty Lieb 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Director Scott Perricelli 432 Park Avenue S. 12th Floor NEW YORK NY NEW YORK 10016 Director Other Health Care Decline to Disclose 06b true 0001412408-17-000001 2017-10-27 false true false 0 Allen & Company LLC 25 None None 711 5th Avenue, #9 NEW YORK NY NEW YORK 10022 All States false 40000000 33999994 6000006 false 4 1000006 true 0 Allen & Company LLC may receive 5% of money raised plus expenses, excluding any funds received from existing stockholders. 0 The Issuer will use proceeds of the offering for general working capital purposes which may include payments to its executive officers and other employees in the ordinary course of business. false Phreesia, Inc. /s/ Thomas Altier Thomas Altier Chief Financial Officer 2017-12-11